 |
¹ÙÀÌ¿À ÀǾàǰ »ý»ê (°úÀå±Þ) (~2021-03-25) |
|
 |
µö·¯´× Ȱ¿ë ½Å¾à °³¹ß (~2021-03-25) |
 |
(ÁÖ)µÎ¿ø½Äǰ ǰÁú°ü¸® Á÷¿ø ä¿ë (~2021-04-23) |
 |
[¾á¼¾ ¹é½Å] Execution System Enginee (ä¿ë½Ã) |
|
 |
[¾á¼¾ ¹é½Å] Sr. Project Engineer (ä¿ë½Ã) |
 |
[Á¸½¼¾ØµåÁ¸½¼ ¸ÞµðÄ®] Sr. Regulatory (ä¿ë½Ã) |
 |
[Çѱ¹¾á¼¾] Clinical Site Payment Lea (ä¿ë½Ã) |
|
 |
B. °Ç°±â´É½Äǰ(À¯»ê±Õ) °³¹ß/¿¬±¸ °ú (~2021-03-24) |
 |
B. Ä¡Áî½Äǰ °³¹ß/¿¬±¸ °æ·ÂÁ÷ (~2021-03-24) |
 |
[ºÎõ] ½Äǰ¾÷ »ý»ê°ü¸® °æ·Â(ÆÀÀå±Þ) (~2021-03-24) |
|
 |
¹Ù¸¥ÇÇÀÚ»ýȰ °æ·ÂÁ÷ ä¿ë (~2021-03-24) |
 |
(ÁÖ)Å×¶óÁ¨¹ÙÀÌ¿À NGS »ç¾÷º»ºÎ ä¿ë (~2021-04-23) |
 |
(ÁÖ)CMGÁ¦¾à µµ¸Å ¿µ¾÷´ã´ç ä¿ë (¼¿ï (~2021-03-26) |
|
 |
2021³âµµ »ó¹Ý±â ǰÁúºÎ¼ ǰÁúº¸ÁõÆÀ( (~2021-02-28) |
 |
21³âµµ »ó¹Ý±â ÇѼֽžà(ÁÖ) »ý»ê»ç¿ø (~2021-02-28) |
 |
SKÇÏÀ̴нº ÀÚȸ»ç Çູ¸ð¾Æ(ÁÖ) »ý»ê (~2021-03-05) |
|
 |
SKÇÏÀ̴нº ÀÚȸ»ç Çູ¸ð¾Æ(ÁÖ) ǰÁú (~2021-03-05) |
 |
R&D °³¹ß(°Ç°½Äǰ) ´ã´çÀÚ (~2021-04-23) |
 |
Ãѹ«/IT/¸¶ÄÉÆÃ Àü·«/SCM/È«º¸/CSV/¼³ (~2021-03-01) |
|
 |
2021³â »ó¹Ý±â °¢ ºÎ¹® °æ·ÂÁ÷ ¸ðÁý °ø (~2021-03-30) |
 |
¹ÙÀÌ¿ÀÀǾàǰ QC & R&D °ü·Ã ¾÷¹« (~2021-03-20) |
 |
SKÇÏÀ̴нº ÀÚȸ»ç Çູ¸ð¾Æ(ÁÖ) Á¦Ç° (~2021-03-05) |
|
 |
[¸ÞÀÌÁØ»ýȰ°Ç°]¿Â¶óÀÎ ¿µ¾÷ ´ã´çÀÚ (~2021-03-24) |
 |
ÀÓ»ó½ÃÇè QCA (Quality Control Associ (~2021-04-23) |
 |
ǰÁú°ü¸®(QC) Ã¥ÀÓÀÚ Ã¤¿ë (~2021-04-23) |
|
 |
¿ø°¡°ü¸®/½Äǰ°¡°ø¡¤°³¹ß Á¤±ÔÁ÷ ¸ðÁý (~2021-04-23) |
 |
Product Manager Á¤±ÔÁ÷ ¸ð (~2021-03-02) |
 |
½ÄǰÁ¦Á¶(¼Ò½º/µå·¹½Ì/º¹ÇÕÁ¶¹Ì½Äǰ)»ý (~2021-03-07) |
|
 |
´ëÇüÁ¦¾à»ç ÇÕ¼º½Å¾à ¾à¸®¿¬±¸¿ø 7³âÀÌ (ä¿ë½Ã) |
 |
Marketing & Clinical Specialist-±Û·Î (~2021-03-24) |
 |
¿£Æ¼¿¤ ½ÅÀÔ/°æ·Â ä¿ë (~2021-03-01) |
|
 |
¾ÆÀ̽ºÅ©¸² °³¹ßÀÚ ( ´ë¸®~°úÀå±Þ )-±¹ (~2021-03-24) |
 |
ÈÀåǰ ÆÄÆ® SCM Manager Àη ä¿ë (~2021-03-24) |
 |
½Äǰ »ý»ê°ü¸® (¼¹«) ½ÅÀÔ ¹× °æ·ÂÁ÷ (~2021-04-23) |
|
 |
(ÁÖ)¹ÙÀÌ¿ÀÁö³ëÄÚ¸®¾Æ ¿¬±¸¿ø ¹× ¿µ¾÷ (~2021-03-01) |
 |
Á¦¾à Áß¾Ó¿¬±¸¼Ò Á¦Ç°¿¬±¸ÆÀ ½ÅÀÔ/°æ·Â (~2021-03-05) |
 |
Á¤±ÔÁ÷ °æ·Â ¹× ½ÅÀÔÁ÷¿ø ¸ðÁý [Áß°£ (~2021-03-19) |
|
 |
½Äǰ°¡°ø¡¤°³¹ß Á¤±ÔÁ÷ ä¿ë(°æ·Â) (~2021-03-14) |
 |
ÀÇ·á±â±â Regulatory Affairs (~2021-03-15) |
 |
¼¿ï¾Æ»êº´¿ø Àӻ󿬱¸º¸È£¼¾ÅÍ Á¤±ÔÁ÷ (~2021-03-07) |
|
 |
[±³Á¤±â¼úÆÀ]±¹°¡°øÀα³Á¤±â°ü ½ÅÀÔ»ç (~2021-03-04) |
 |
¹ÙÀÌ¿À ¿¬±¸°³¹ß/±âȹ (~2021-03-02) |
 |
Ãà»ê¹° °¡°øÀå »ý»êÁ÷ ¸ðÁý(°ñÀý±â »ç (~2021-04-23) |
|
 |
Çѱ¹¾Æ½ºÆ®¶óÁ¦³×Ä« CRA ¸ð (~2021-03-31) |
 |
ÀǾàǰÀÎÇã°¡, ÈÀåǰ, ½Äǰ ¿Ü ½ÅÀÔ (~2021-03-08) |
 |
ÀÓ»ó°³¹ß/GMP/¿¬±¸¼Ò ½ÅÀÔ ¹× °æ·ÂÁ÷ (~2021-03-08) |
|
 |
HMR Á¦Ç°°³¹ß ÆÀÀå (ä¿ë½Ã) |
 |
Á¦Ç°µðÀÚÀÎ, Á¦Ç°°³¹ß´ã´çÀÚ - °¢ ºÐ¾ß (~2021-03-24) |
 |
(Jr.) Clinical Research As (~2021-03-31) |
|
 |
½Äǰ ǰÁú°ü¸®(HACCP) Á÷¿øÀ» ¸ðÁýÇÕ´Ï (~2021-03-05) |
 |
[Neonutra] ³×¿À´ºÆ®¶ó(ÁÖ) CRA Á¤±ÔÁ÷ (~2021-03-01) |
 |
[ÄÚ½º¸Æ½º¿£ºñƼ(ÁÖ)] ¿¬±¸±âȹ (°æ·Â) (ä¿ë½Ã) |
|
 |
Ä¿ÇÇ ÇÁ·£Â÷ÀÌÁî ½ÄÀ½·á ¿¬±¸°³¹ß(R&D) (~2021-03-01) |
 |
¾ËÇǹÙÀÌ¿À ¿ø·á, ¿µ¾÷, °³¹ß¸¶ÄÉÆÃ, (~2021-03-07) |
 |
Á¦Ç° °ü¸® (Ãâ°í ¹× Áö°ÔÂ÷) Á¤±ÔÁ÷ Á÷ (~2021-04-23) |
|
 |
»ý»êÆÀ ½ÅÀÔ ¹× °æ·Â ä¿ë (~2021-02-26) |
 |
(ÁÖ)¿¢¼¿¼¼¶óǻƽ½º R&D Àη ¸ðÁý (~2021-04-23) |
 |
[ÄÚ½º´Ú»óÀå»ç] ¿¬±¸±âȹ(°úÁ¦±âȹ, Á¦ (~2021-03-24) |
|
 |
(ÁÖ)°í¹ÙÀÌ¿À·¦ ½ÅÀÔ ¹× °æ·ÂÁ÷ ¿¬±¸¿ø (~2021-04-23) |
 |
°Ç°±â´É½Äǰ OEM ¿µ¾÷ °æ·Â»ç¿ø ¸ðÁý( (~2021-03-03) |
 |
[ RA´ã´çÀÚ, ÃѰæ·Â 6-12³â - ±Û·Î¹ú (~2021-03-05) |
|
 |
¿ø·áÀǾàǰ »ý»êºÎ ( Á¤Á¦ÆÄÆ® ) ½ÅÀÔ& (~2021-04-23) |
 |
À¯¸í Á¦¾à»ç Á¦Á¶°ü¸® Â÷Àå,ºÎÀå±Þ (~2021-03-24) |
 |
[¿Ü±¹°è ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷/±¤±³] GMP (ä¿ë½Ã) |
|
 |
[¿Ü±¹°è ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷/±¤±³] CEO (ä¿ë½Ã) |
 |
À¯¸í Á¦¾à»ç ǰÁúº¸Áõ °úÀå,Â÷Àå,ºÎÀå (~2021-03-09) |
 |
[´ëÀü°øÀå] »ý»ê°ü¸® ½ÅÀÔ/°æ·Â Ãæ¿ø (ä¿ë½Ã) |
|
 |
[±×·ì»ç ´ë±â¾÷] Ãà»ê ¸¶ÄÉÆÃ °æ·Â ä (~2021-03-01) |
 |
¿Ü±¹°è ÀÓ»ó Project Manager °æ·Â»ç¿ø (ä¿ë½Ã) |
 |
³ªÆú·¹¿Ë°úÀÚÁ¡ »ý»êº¸Á¶ Á÷¿ø ¹× PT (~2021-03-24) |
|
 |
[À¯¸Á¹ÙÀÌ¿Àȸ»ç] ¿¬±¸Áö¿ø°ü¸® ¾÷¹«( (~2021-03-24) |
 |
¹Ì»ý¹°¹è¾ç±â ½ÅÁ¦Ç°°³¹ß »ý¸í°øÇÐ/È (~2021-04-23) |
 |
[À¯¸Á¹ÙÀÌ¿Àȸ»ç] ¿¬±¸ CMC Manager(°æ (~2021-03-24) |
|
 |
[±¹³»¹ÙÀÌ¿Àȸ»ç] ÀüÀÓ»ó(¾à¸®/µ¶¼º) (~2021-03-24) |
 |
[À¯¸Á¹ÙÀÌ¿Àȸ»ç] ½Å¾à ºñÀÓ»ó ¾à¸® ¹Ú (~2021-03-24) |
 |
[±¹³»¹ÙÀÌ¿Àȸ»ç] ¸é¿ªÇ×¾ÏÁ¦ ½Å¾à°³¹ß (~2021-03-24) |
|
 |
[À¯¸Á¹ÙÀÌ¿Àȸ»ç] ¼¼Æ÷Ä¡·áÁ¦ RA Manag (~2021-03-24) |
 |
[À¯¸Á¹ÙÀÌ¿Àȸ»ç] ¹ÙÀÌ¿ÀÀǾàǰ ¿¬±¸°³ (~2021-03-24) |
 |
Á¦¾à, ¹ÙÀÌ¿À ¿¬±¸ºÎ¹®(R&D, R&D Plann (~2021-03-24) |
|
 |
Çѱ¹ÀǾ࿬±¸¼Ò ÀÓ»ó½ÃÇè CRA / PM / C (~2021-03-24) |
 |
¿¥µð¿¡½ºÄÚ¸®¾Æ ǰÁú°ü¸®ºÎ ½ÅÀÔ, °æ·Â (~2021-04-23) |
 |
[±×·ì»ç ½Äǰ ´ë±â¾÷]Ãà»ê ¿µ¾÷ (°æ·Â (~2021-03-01) |
|
 |
QC Supervosor/ Global Healthcare Com (~2021-03-08) |
 |
½Å¾à°³¹ß¹ÙÀÌ¿ÀÀ̹Ì¡ ½ÃÇè´ã´çÀÚ(¹ÙÀÌ (~2021-03-15) |
 |
Validation ÆÀÀå/±¹³»Á¦¾àȸ»ç (~2021-03-08) |
|
 |
Pharmacovigilance ´ã´ç/±¹³»Á¦¾àȸ»ç (~2021-03-08) |
 |
Component Engineer¿Ü±¹°èÇコÄɾîȸ»ç (~2021-03-08) |
 |
¿¬±¸¿ø(Digital ½Å¼Ó¸é¿ªÁø´ÜŰƮ) (~2021-03-08) |
|
 |
¿¬±¸±âȹ´ã´ç/¿Ü±¹°èÇコÄɾîȸ»ç (~2021-03-08) |
 |
¿¬±¸¿ø(Project Manager/¿Ü±¹°èÇコÄÉ (~2021-03-08) |
 |
À¯ÇØÈÇй°Áú °ü¸®´ã´ç/ Global Health (~2021-03-08) |
|
 |
ÀÓ»ó°³¹ß °æ·ÂÁ÷(±¹³»¹ÙÀÌ¿À±â¾÷) (~2021-03-24) |
 |
¿ø·á°³¹ß´ã´ç/¿Ü±¹°èÇコÄɾîȸ»ç/Áø´Ü (~2021-03-08) |
 |
[ÀÓ»ó½ÃÇè ¼öʱâ°ü(CRO)] ÀÓ»óPM ä¿ë (~2021-03-24) |
|
 |
ÀÚµ¿ÈÇÁ·ÎÁ§Æ® ¿£Áö´Ï¾î/¿Ü±¹°èÇコÄÉ (~2021-03-08) |
 |
»ý»ê±â¼ú ¿£Áö´Ï¾î/ Global Healthcare (~2021-03-08) |
 |
Electric Engineer/ Global Healthcare (~2021-03-08) |
|
 |
¿ø·áÀǾàǰ DMF µî·Ï (RA) (~2021-03-01) |
 |
Á¦¾à GMP Validation ¾÷¹« Èñ¸ÁÀÚ (~2021-04-23) |
 |
Çѱ¹ÄÚ·¯½º(ÁÖ) ºÎ¹®º° ¿¬±¸¿ø ¸ðÁý ( (~2021-04-23) |
|
 |
(ÁÖ)ÄͿ ¼ö½Ãä¿ë (~2021-03-01) |
 |
°øÁ¤°ü¸® ½ÅÀÔ Ã¤¿ë(Á¤±ÔÁ÷) (ä¿ë½Ã) |